PJXA.SG
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
5 more panels on PJXA.SG open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $89.19B | $91.42B | $102.41B | $124.47B | -2.4% |
| Operating revenue | $89.19B | $91.42B | $102.41B | $124.47B | -2.4% |
| Cost of revenue | $46.74B | $45.44B | $48.44B | $59.49B | +2.8% |
| Gross profit | $42.46B | $45.97B | $53.97B | $64.99B | -7.6% |
| Research & development | $864.00M | $789.00M | $726.00M | $792.00M | +9.5% |
| Selling, general & admin | $8.87B | $9.03B | $8.06B | $7.00B | -1.8% |
| Total operating expense | $14.70B | $20.28B | $14.50B | $11.72B | -27.5% |
| Operating income | $27.76B | $25.69B | $39.47B | $53.27B | +8.0% |
| Net interest income | -$3.95B | -$4.01B | -$3.71B | -$2.83B | +1.5% |
| Pre-tax income | $26.80B | $11.14B | $35.40B | $53.52B | +140.5% |
| Tax provision | $7.08B | $3.54B | $10.40B | $16.77B | +100.0% |
| Net income | $19.63B | $7.53B | $24.88B | $36.62B | +160.8% |
| Net income to common | $19.63B | $7.53B | $24.88B | $36.62B | +160.8% |
| Basic EPS | 3.04 | 1.17 | 3.82 | 5.62 | +160.2% |
| Diluted EPS | 3.04 | 1.17 | 3.82 | 5.62 | +160.2% |
| EBIT | $30.89B | $14.98B | $39.01B | $56.72B | +106.2% |
| EBITDA | $46.04B | $27.46B | $52.29B | $69.93B | +67.6% |
| Basic shares | 6.44B | 6.44B | 6.51B | 6.52B | -0.0% |
| Diluted shares | 6.44B | 6.44B | 6.51B | 6.52B | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $6.47B | $3.27B | $12.73B | $8.00B | +97.8% |
| Cash & short-term investments | $9.20B | $7.53B | $15.55B | $10.77B | +22.1% |
| Accounts receivable | $4.63B | $3.57B | $6.13B | $5.01B | +29.8% |
| Inventory | $8.21B | $6.71B | $7.68B | $8.78B | +22.4% |
| Total current assets | $25.45B | $21.84B | $32.45B | $31.25B | +16.5% |
| Property, plant & equipment | $168.04B | $136.28B | $153.42B | $130.17B | +23.3% |
| Goodwill & intangibles | $2.52B | $2.25B | $3.04B | $2.99B | +11.9% |
| Total assets | $222.34B | $181.65B | $217.07B | $187.19B | +22.4% |
| Total current liabilities | $36.05B | $31.46B | $33.86B | $31.38B | +14.6% |
| Current debt | $2.19B | $2.57B | $4.32B | $3.58B | -14.8% |
| Long-term debt | $24.25B | $20.60B | $24.48B | $26.38B | +17.8% |
| Total debt | $69.79B | $60.31B | $62.60B | $53.80B | +15.7% |
| Total liabilities | $146.45B | $122.30B | $138.09B | $117.36B | +19.7% |
| Shareholder equity | $75.56B | $59.11B | $78.58B | $69.49B | +27.8% |
| Working capital | -$10.60B | -$9.62B | -$1.42B | -$130.00M | -10.2% |
| Net tangible assets | $73.04B | $56.85B | $75.54B | $66.51B | +28.5% |
| Shares issued | 12.89B | 13.04B | 13.04B | 13.04B | -1.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $19.72B | $7.61B | $25.00B | $36.76B | +159.3% |
| Depreciation & amortisation | $15.15B | $12.48B | $13.28B | $13.22B | +21.4% |
| Change in working capital | -$4.46B | -$3.69B | -$3.81B | -$9.17B | -20.8% |
| Operating cash flow | $36.05B | $37.98B | $43.21B | $49.72B | -5.1% |
| Capital expenditure | -$19.52B | -$14.64B | -$12.11B | -$9.58B | -33.3% |
| Investing cash flow | -$15.64B | -$13.37B | -$7.96B | -$432.00M | -17.0% |
| Share buybacks | $0 | -$380.00M | -$735.00M | $0 | +100.0% |
| Dividends paid | -$8.11B | -$18.33B | -$19.67B | -$37.70B | +55.7% |
| Financing cash flow | -$17.41B | -$33.09B | -$30.70B | -$51.45B | +47.4% |
| Free cash flow | $16.53B | $23.34B | $31.10B | $40.14B | -29.2% |
| End cash position | $6.47B | $3.27B | $12.73B | $8.00B | +97.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $33.61B | $23.48B | $23.61B | $23.48B | $21.04B | — | +43.1% |
| Operating revenue | $33.61B | $23.48B | $23.61B | $23.48B | $21.04B | — | +43.1% |
| Cost of revenue | $14.11B | $12.17B | $12.77B | $12.26B | $11.03B | — | +16.0% |
| Gross profit | $19.49B | $11.32B | $10.84B | $11.22B | $10.01B | — | +72.3% |
| Research & development | $296.00M | $249.86M | $236.00M | $233.00M | $193.00M | — | +18.5% |
| Selling, general & admin | $3.14B | $3.13B | $2.24B | $1.59B | $2.27B | — | +0.3% |
| Total operating expense | $5.42B | $4.51B | $3.56B | $3.49B | $4.46B | — | +20.3% |
| Operating income | $14.07B | $6.81B | $7.28B | $7.73B | $5.55B | — | +106.7% |
| Net interest income | -$937.00M | -$191.38M | -$1.07B | -$1.02B | -$945.00M | — | -389.6% |
| Pre-tax income | $14.07B | $9.33B | $3.00B | $8.28B | $6.41B | — | +50.8% |
| Tax provision | $3.63B | $3.11B | $80.00M | $2.23B | $1.65B | — | +16.8% |
| Net income | $10.43B | $6.20B | $2.90B | $6.03B | $4.73B | — | +68.2% |
| Net income to common | $10.43B | $6.20B | $2.90B | $6.03B | $4.73B | — | +68.2% |
| Basic EPS | 1.62 | 0.96 | — | 0.94 | 0.74 | 0.95 | +68.6% |
| Diluted EPS | 1.62 | 0.96 | — | 0.94 | 0.74 | 0.95 | +68.6% |
| EBIT | $15.01B | $9.26B | $4.03B | $9.36B | $7.44B | — | +62.2% |
| EBITDA | $19.28B | $13.36B | $8.12B | $13.47B | $11.09B | — | +44.3% |
| Basic shares | 6.44B | 6.44B | — | 6.44B | 6.40B | 6.44B | -0.1% |
| Diluted shares | 6.44B | 6.44B | — | 6.44B | 6.40B | 6.44B | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.48B | $6.51B | $6.47B | $8.96B | $7.00B | — | -0.4% |
| Cash & short-term investments | $10.39B | $9.04B | $9.20B | $11.66B | $9.50B | — | +14.9% |
| Accounts receivable | $6.25B | $4.22B | $4.63B | $4.12B | $3.38B | — | +48.1% |
| Inventory | $9.72B | $9.22B | $8.21B | $8.70B | $8.23B | — | +5.4% |
| Total current assets | $29.94B | $26.68B | $25.45B | $28.08B | $24.90B | — | +12.2% |
| Property, plant & equipment | $185.69B | $179.20B | $168.04B | $171.56B | $163.63B | — | +3.6% |
| Goodwill & intangibles | $2.73B | $2.66B | $2.52B | $2.52B | $2.43B | — | +2.8% |
| Total assets | $247.08B | $236.58B | $222.34B | $227.89B | $215.30B | — | +4.4% |
| Total current liabilities | $35.04B | $35.92B | $36.05B | $34.29B | $32.83B | — | -2.4% |
| Current debt | $1.44B | $2.46B | $2.19B | $2.48B | $2.48B | — | -41.7% |
| Long-term debt | $24.40B | $24.83B | $24.25B | $25.64B | $23.32B | — | -1.7% |
| Total debt | $70.81B | $70.57B | $69.79B | $70.71B | $68.06B | — | +0.3% |
| Total liabilities | $153.99B | $151.83B | $146.45B | $147.99B | $141.67B | — | +1.4% |
| Retained earnings | $14.82B | — | — | $13.20B | $8.69B | $5.97B | — |
| Shareholder equity | $92.91B | $84.52B | $75.56B | $79.52B | $73.16B | — | +9.9% |
| Working capital | -$5.10B | -$9.23B | -$10.60B | -$6.21B | -$7.94B | — | +44.8% |
| Net tangible assets | $90.18B | $81.87B | $73.04B | $77.00B | $70.73B | — | +10.2% |
| Shares issued | 12.89B | 12.89B | 12.89B | 12.89B | 12.89B | — | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $10.44B | $6.22B | $2.92B | $6.05B | $4.62B | — | +67.8% |
| Depreciation & amortisation | — | — | $7.60B | $605.00M | $3.70B | $3.25B | — |
| Change in working capital | -$4.13B | -$1.87B | $267.00M | -$1.84B | -$1.76B | — | -121.3% |
| Operating cash flow | $12.30B | $8.35B | $10.16B | $9.86B | $7.47B | — | +47.3% |
| Capital expenditure | -$4.57B | -$4.51B | -$6.59B | -$4.89B | -$4.00B | — | -1.3% |
| Investing cash flow | -$5.72B | -$3.57B | -$6.55B | -$4.76B | -$2.55B | — | -60.3% |
| Share buybacks | — | — | $0 | $0 | $0 | $0 | — |
| Dividends paid | -$1.53B | -$2.21B | -$1.50B | -$2.03B | -$1.71B | — | +30.7% |
| Financing cash flow | -$6.70B | -$4.74B | -$6.03B | -$3.22B | -$2.70B | — | -41.5% |
| Free cash flow | $7.73B | $3.84B | $3.57B | $4.97B | $3.46B | — | +101.3% |
| End cash position | $6.48B | $6.51B | $6.47B | $8.96B | $7.00B | — | -0.4% |
Options analytics
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 3, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Apr 17, 26 | B of A Securities | UPGRADE | Neutral | Buy |
| Mar 13, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Feb 11, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Jan 14, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 22, 25 | UBS | MAINTAINED | Buy | Buy |
| May 15, 25 | Jefferies | UPGRADE | Hold | Buy |
| Apr 22, 25 | UBS | MAINTAINED | Buy | Buy |
| Nov 12, 24 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Sep 25, 24 | JP Morgan | UPGRADE | Neutral | Overweight |
| Sep 18, 24 | B of A Securities | MAINTAINED | Buy | Buy |
| Aug 26, 24 | Morgan Stanley | UPGRADE | Equal-Weight | Overweight |
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.